Concepedia

Author

Toshikazu Akiya

Saitama Cancer Center

Also Known As

T Akiya, T. Akiya, TOSHIKAZU AKIYA, Toshikazu AKIYA, Toshikazu Akiya

20

Publications

2.2K

Citations

8

H-Index

15

Concepts

All Affiliations

Saitama Cancer CenterShowa UniversityKitasato UniversityKitasato University East HospitalNagasaki Medical Center
TA

About

Toshikazu Akiya is an author at Saitama Cancer Center specializing in oncology, medicine, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

2K

2

Gastroenterology

4

4

2K

3

Health Sciences

2

2

94

4

Pharmacology

2

2

94

5

Pathology

1

1

52

Toshikazu Akiya

×

8

Publications

2.2K

Citations

8

H-Index

YearCitations

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara,

The Lancet Oncology

2008

1.9K

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

Kensei Yamaguchi, T Shimamura, Ichinosuke Hyodo,

British Journal of Cancer

2006

68

Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) <i>SPIRITS:</i> S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer

H. Narahara, Wasaburo Koizumi, Takuo Hara,

Journal of Clinical Oncology

2007

52

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

Wasaburo Koizumi, Minoru Kurihara, T Sasai,

Cancer

1993

45

Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study

Wasaburo Koizumi, Toshikazu Akiya, Atsushi Satō,

Cancer Chemotherapy and Pharmacology

2009

42

A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer

Minoru Kurihara, T. Izumi, Shigeaki Yoshida,

Japanese Journal of Cancer Research

1991

42

Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative Oncology Group, TCOG GC-0501 Trial

Wasaburo Koizumi, Toshikazu Akiya, Akihiro Sato,

Japanese Journal of Clinical Oncology

2009

34

Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer.

Wasaburo Koizumi, Yoshio Fukuyama, Takahiro Fukuda,

PubMed

2004

14

Page 1